Company Data

Innoviva Inc.

Ticker
INVA
Current Price
$19.95 -2.78%
Market Cap
$1.3B
Price Target
Refer to Report
Volume
516.0K
52wk Range
$16.67 - $22
Advanced Market Data

Overview

Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance’s respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy